Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Lifen Cao"'
Publikováno v:
Cancer Medicine, Vol 12, Iss 19, Pp 19607-19616 (2023)
Abstract Background Validation studies of the 21‐gene recurrence score (RS) previously demonstrated that adjuvant chemotherapy plus endocrine therapy (CET) was associated with a significant survival benefit in women with node negative breast cancer
Externí odkaz:
https://doaj.org/article/1e231321697746d6ad6543a1abb9eae6
Autor:
Nickolas Stabellini, Jennifer Cullen, Lifen Cao, John Shanahan, Nelson Hamerschlak, Kristin Waite, Jill S. Barnholtz-Sloan, Alberto J. Montero
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract The main objective of this work was to perform a comprehensive analysis and provide a race-stratified epidemiological report accounting for differences in treatment patterns and treatment related adverse events in Non-Hispanic women with bre
Externí odkaz:
https://doaj.org/article/5f27e2b0610c4b2dad3725ff678ed6df
Autor:
Nickolas Stabellini, Lifen Cao, Christopher W. Towe, Xun Luo, Amanda L. Amin, Alberto J. Montero
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe RxPONDER trial found that among breast cancer patients with estrogen receptor positive (ER+) breast cancer, 1-3 positive axillary nodes, and a recurrence score of ≤25, only pre-menopausal women benefitted from adjuvant chemoendocrine
Externí odkaz:
https://doaj.org/article/4013ba368b0840f3b7b623714ea19cec
Autor:
Nickolas Stabellini, MS, Debora S. Bruno, MD, MS, Mantas Dmukauskas, PhD, Amie J. Barda, PhD, Lifen Cao, MD, PhD, John Shanahan, BA, Kristin Waite, PhD, Alberto J. Montero, MD, PhD, Jill S. Barnholtz-Sloan, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 4, Pp 100307- (2022)
Introduction: Lung cancer is the leading cause of cancer-related death and the second most often diagnosed malignancy worldwide. Males have higher incidence of lung cancer and higher mortality. It is hypothesized that the sex differences in survival
Externí odkaz:
https://doaj.org/article/71710e1ca9ad4463a192b5fb5795ebde
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/f95d811e14cd46a7b95b469286f262d0
Autor:
Lifen Cao, Robert Shenk, Nickolas Stabellini, Amanda L. Amin, Alberto J. Montero, Christopher W. Towe
Publikováno v:
Journal of Surgical Research. 285:114-120
Autor:
Lifen Cao, Philip A. Linden, Tithi Biswas, Stephanie G. Worrell, Jillian N. Sinopoli, Megan E. Miller, Robert Shenk, Alberto J. Montero, Christopher W. Towe
Publikováno v:
Journal of Surgical Research. 283:532-539
Publikováno v:
The American Journal of Surgery. 225:75-83
Despite evidence that early-stage male breast cancer (MBC) can be treated the same as in females, we hypothesized that men undergo more extensive surgery.Patients with clinical T1-2 breast cancer were identified in the National Cancer Database 2004-2
Autor:
David A. Boothman, Jinming Gao, Douglas R. Spitz, Donald J. Buchsbaum, William G. Bornmann, David M. Euhus, Cheryl Lewis, Michael Boatman, Amy Rommel, Zachary Moore, Lifen Cao, Malina Patel, Long Shan Li, John J. Pink, Vernon E. Anderson, Marie Varnes, Melissa C. Srougi, Kathryn E. Reinicke, Erik A. Bey
PDF file, 1661K, Supplemental Figure S1- Chemical Structures. Supplemental Figure S2-Oxygen Consumption in MCF-7 Cells treated with or without betalapchone and dicoumarol. Supplemental Figure S2 legend. Supplemental Figure S3-Survival assay for norma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b0292db08a0f90fe3921f701ed3216c
https://doi.org/10.1158/1535-7163.22498413.v1
https://doi.org/10.1158/1535-7163.22498413.v1
Autor:
Nickolas Stabellini, Jennifer Cullen, Justin X. Moore, Lifen Cao, Neeraj Agarwal, Nelson Hamerschlak, Kristin Waite, Alberto J. Montero, Jill S. Barnholtz-Sloan, Avirup Guha
Publikováno v:
JACC: CardioOncology. 4:555-557